JP2009519001A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519001A5
JP2009519001A5 JP2005510048A JP2005510048A JP2009519001A5 JP 2009519001 A5 JP2009519001 A5 JP 2009519001A5 JP 2005510048 A JP2005510048 A JP 2005510048A JP 2005510048 A JP2005510048 A JP 2005510048A JP 2009519001 A5 JP2009519001 A5 JP 2009519001A5
Authority
JP
Japan
Prior art keywords
polynucleotide
seq
snp
allele
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005510048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040977 external-priority patent/WO2004058990A2/en
Publication of JP2009519001A publication Critical patent/JP2009519001A/ja
Publication of JP2009519001A5 publication Critical patent/JP2009519001A5/ja
Pending legal-status Critical Current

Links

JP2005510048A 2002-12-20 2003-12-22 狭窄に関連する遺伝的多型、その検出方法および使用 Pending JP2009519001A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43474102P 2002-12-20 2002-12-20
US45305003P 2003-03-10 2003-03-10
US46643703P 2003-04-30 2003-04-30
PCT/US2003/040977 WO2004058990A2 (en) 2002-12-20 2003-12-22 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof

Publications (2)

Publication Number Publication Date
JP2009519001A JP2009519001A (ja) 2009-05-14
JP2009519001A5 true JP2009519001A5 (enExample) 2009-06-25

Family

ID=32686076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005510048A Pending JP2009519001A (ja) 2002-12-20 2003-12-22 狭窄に関連する遺伝的多型、その検出方法および使用

Country Status (6)

Country Link
US (2) US7306913B2 (enExample)
EP (1) EP1583770A4 (enExample)
JP (1) JP2009519001A (enExample)
AU (1) AU2003299817A1 (enExample)
CA (1) CA2510895A1 (enExample)
WO (1) WO2004058990A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613774A2 (en) 2003-03-10 2006-01-11 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
WO2005110039A2 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
FI20041340A0 (fi) * 2004-10-15 2004-10-15 Jurilab Ltd Oy Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi
US20060278241A1 (en) * 2004-12-14 2006-12-14 Gualberto Ruano Physiogenomic method for predicting clinical outcomes of treatments in patients
US7747392B2 (en) * 2004-12-14 2010-06-29 Genomas, Inc. Physiogenomic method for predicting clinical outcomes of treatments in patients
WO2007028147A2 (en) * 2005-09-01 2007-03-08 Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
US7799530B2 (en) * 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
DE102005048899A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen
WO2007047634A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of California Method to diagnose, predict treatment response and develop treatments for psychiatric disorders using markers
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
EP2472258A3 (en) 2006-04-04 2012-11-28 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US20080027756A1 (en) * 2006-06-30 2008-01-31 Richard Gabriel Systems and methods for identifying and tracking individuals
US7651840B2 (en) 2006-07-14 2010-01-26 Celera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
US7569221B2 (en) * 2006-11-10 2009-08-04 Health Research, Inc. Compositions and methods for identifying agents that alter expression of survivin
WO2008088836A2 (en) * 2007-01-16 2008-07-24 The Burnham Institute For Medical Research Compositions and methods for treatment of colorectal cancer
US8043815B2 (en) * 2007-08-06 2011-10-25 Health Research, Inc. Methods for analysis of PDEF and survivin as interconnected cancer biomarkers and targets for personalized medicine
US20100233702A1 (en) * 2007-10-04 2010-09-16 The Regents Of The University Of California Method to predict response to treatment for psychiatric illnesses
WO2009073628A2 (en) * 2007-11-30 2009-06-11 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
JP5873335B2 (ja) * 2009-02-12 2016-03-01 ヤンセン バイオテツク，インコーポレーテツド フィブロネクチンｉｉｉ型ドメインに基づくスカフォールド組成物、方法及び使用
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
DK2545189T3 (en) * 2010-03-08 2018-04-23 Dana Farber Cancer Inst Inc COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE
US20130098834A1 (en) * 2010-06-22 2013-04-25 Jjk Medical Ltd. Medium, devices and methods
CA2804154C (en) * 2010-07-01 2021-06-01 The Texas A&M University System Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function
US11869024B2 (en) * 2010-09-22 2024-01-09 The Nielsen Company (Us), Llc Methods and apparatus to analyze and adjust demographic information
WO2012051301A1 (en) 2010-10-12 2012-04-19 President And Fellows Of Harvard College Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
US20140044668A1 (en) * 2011-02-15 2014-02-13 The Ohio State University Methods for Predicting Cardiovascular Risks and Responsiveness to Statin Therapy Using SNPs
EP2691541B1 (en) 2011-03-31 2017-10-18 Dana-Farber Cancer Institute, Inc. Method for enriching in single-stranded mutant sequences from mixture of wild-type and mutant sequences
US8703425B2 (en) * 2011-09-12 2014-04-22 The Chinese University Of Hong Kong Biomarker for gastric cancer
US9938576B1 (en) 2012-09-21 2018-04-10 Ohio State Innovation Foundation Materials and methods for determining metabolizer status in humans
WO2015013166A1 (en) 2013-07-24 2015-01-29 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable enrichment of minor dna alleles by limiting denaturation time in pcr or simply enable enrichment of minor dna alleles by limiting denaturation time in pcr
US11607461B2 (en) * 2016-03-23 2023-03-21 University Of Maryland, Baltimore Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
CA3046953A1 (en) 2016-12-12 2018-06-21 Dana Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection
EP3434688A1 (en) 2017-07-24 2019-01-30 Commissariat à l'Energie Atomique et aux Energies Alternatives Hla-g transcripts and isoforms and their uses
WO2019023243A1 (en) 2017-07-24 2019-01-31 Dana-Farber Cancer Institute, Inc. METHODS AND COMPOSITIONS FOR SELECTING AND AMPLIFYING DNA TARGETS IN A SINGLE REACTION MIXTURE
JP2021519581A (ja) 2018-04-03 2021-08-12 ストライドバイオ，インコーポレイテッド 抗体を回避するウイルスベクター
SG11202009452WA (en) 2018-04-03 2020-10-29 Stridebio Inc Antibody-evading virus vectors
AU2019247191A1 (en) 2018-04-03 2020-10-15 Ginkgo Bioworks, Inc. Virus vectors for targeting ophthalmic tissues
EP3810647A4 (en) * 2018-04-26 2022-08-17 The University of North Carolina at Chapel Hill METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMOPHILIA
WO2020150832A1 (en) * 2019-01-24 2020-07-30 Valorisation-Hsj, Limited Partnership Cell-specific transcriptional regulatory sequences and uses thereof
CA3128973A1 (en) 2019-03-04 2020-09-10 Bhaskar Bhattacharyya Data compression and communication using machine learning
AR118465A1 (es) 2019-03-21 2021-10-06 Stridebio Inc Vectores de virus adenoasociados recombinantes
CA3157700A1 (en) 2019-10-17 2021-04-22 Stridebio, Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
CA3189878A1 (en) 2020-08-19 2022-02-24 Colin O'BANION Adeno-associated virus vectors for treatment of rett syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09238688A (ja) 1996-03-11 1997-09-16 Takeda Chem Ind Ltd ヒトｍｃｐ−１レセプタータンパク質の製造法および用途
EP1100963A2 (en) 1998-07-25 2001-05-23 AstraZeneca AB Human ccr-2 gene polymorphisms
ES2311459T3 (es) * 1999-05-24 2009-02-16 Interleukin Genetics Inc Diagnostico de restenosis.
WO2001015676A2 (en) * 1999-09-01 2001-03-08 University Of British Columbia Compositions and methods for modulating hdl cholesterol and triglyceride levels
GB0004183D0 (en) 2000-02-22 2000-04-12 Smithkline Beecham Plc New use
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
JP2003304875A (ja) * 2002-04-15 2003-10-28 Nippon Oil Corp カンタキサンチンの製造方法
JP4140329B2 (ja) 2002-09-25 2008-08-27 財団法人名古屋産業科学研究所 高血圧のリスク診断方法
US7017061B2 (en) * 2003-05-21 2006-03-21 Dell Products L.P. Method and system for dynamically adjusting power consumption of an information handling system

Similar Documents

Publication Publication Date Title
JP2009519001A5 (enExample)
JP2009519703A5 (enExample)
JP2009509508A5 (enExample)
JP2009523005A5 (enExample)
JP2009521905A5 (enExample)
GB2456669A (en) Assay ligates random primers to microarray probes to increase efficiency
US7638310B2 (en) Method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
JP2009533066A5 (enExample)
US20060073511A1 (en) Methods for amplifying and analyzing nucleic acids
WO2012171990A1 (en) Discrimination of blood type variants
JP2006521812A5 (enExample)
JP2004000154A (ja) 核酸の配列特異的検出
EP1612282B1 (en) Probe set and substrate for detecting nucleic acid
JP2009523006A5 (enExample)
JP2008278779A (ja) 核酸ハイブリダイゼーション用溶液
JP5681217B2 (ja) 分枝状ｄｎａ複合体の形成促進を通じた核酸検出方法
US20160060696A1 (en) Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w)
JP2003511056A5 (enExample)
JP2008079604A (ja) アルコール分解能と宿酔の耐性とを予測するためのプライマーセット、プローブセット、方法及びキット
JP3581711B2 (ja) 塩基変異の検出法
CA2374816A1 (en) A marker specific for escherichia coli serotypes o157:h7; o157:nm and 055:h7
AU2002357968A1 (en) Method and integrated device for the detection of cytosine methylations
JP2023536385A (ja) コロナウイルスを含む呼吸器ウイルスを検出する構成物および方法
EP1816195A1 (en) Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid
EP1762628B1 (en) Detection method of homologous sequences differing by one base on a microarray